Table 2.
Targeting inflammatory pathways | Targeting degenerative pathways | Nonpharmacological therapeutic options | |
---|---|---|---|
Treatment agent | • Corticosteroids | • Arimoclomol | • Exercise |
• Intravenous immunoglobulins | • Rapamycin | • Cricopharyngeal myotomy | |
• Bimagrumab* | • Pharyngoesophageal dilation | ||
• Methotrexate | • Follistatin* | ||
• Azathioprine | • Oxandrolone* | ||
• β-Interferon-1a | |||
• Anti-T-lymphocyte globulin | |||
• Etanercept | |||
• Alemtuzumab | |||
• Anakinra | |||
• Simvastatin |
*Increases muscle mass